ABSTRACT: Differences in innate disease resistance at the sub-species level have major implications for wildlife management. virginianus texanus fawns. Virus titers and humoral immune response were similar in both subspecies suggesting that differences in innate disease resistance explain the differences seen in clinical disease severity. In white-tailed deer, innate disease resistance may vary at the subspecies level. Should this phenomenon occur in other species, these findings have major implications for managing wildlife populations, both endangered and non-endangered, using tools such as translocation and captive propagation.
INTRODUCTION
Hemorrhagic disease (HD), the most important infectious disease of whitetailed deer (Odocoileus virginianus) , is caused by orbiviruses in the epizootic hemorrhagic disease (EHD) virus or bluetongue (BT) virus serogroups (Nettles and Stallknecht, 1992) . Of the two serogroups, the EHD viruses are most often associated with infection in white-tailed deer populations in the southeastern United States (Nettles et al., 1992) . Clinical HD, initiated by viral replication in vascular endothelial cells, is characterized by intravascular thrombosis, disseminated intravascular coagulation, and hemorrhagic diathesis, often resulting in mortality (Tsai and Karstad, 1973; Howerth et al., 1988) .
Spatially, HD is not uniformly distributed throughout the United States. Epizootics in northern latitudes are infrequent and characterized by severe clinical disease and mortality, whereas epizootics in southern latitudes are more frequent and often result in mild or inapparent disease (Davidson and Doster, 1997) . Extreme southern latitudes in the US such as in Texas are thought to represent areas of enzootic stability, where EHD and BT viruses are endemic, but disease is rarely seen due to a near perfect host-virus relationship . Interactions among vectors (Culicoides spp.), virus strain and virulence, and herd immunity have been suggested as causes for these distinct geographic patterns of HD distribution (Nettles and Stallknecht, 1992) . We hypothesized that these factors have ultimately influenced evolution of the host, which results in extreme differences in host innate resistance (Nettles and Stallknecht, 1992) . Odocoileus virginianus borealis is a northern white-tailed deer subspecies found outside of the known endemic area for EHD viruses (Baker, 1984) , and O. virginianus texanus is a southern subspecies that occurs within the known EHD virus-endemic area (Baker, 1984) . We infected fawns from Pennsylvania (O. virginianus borealis; PA fawns) and fawns from Texas (O. virginianus texanus; TX fawns) with both EHD virus serotypes known to occur in the United States to determine if innate resistance to clinical disease varied between these white-tailed deer subspecies. Ten fawns of each subspecies were moved by 2 wk of age to an indoor facility at the University of Georgia (Athens, Georgia, USA) in June and July 2000. Fawns were first tested for antibodies to EHD and BT viruses on July 17 using agar gel immunodiffusion (Veterinary Diagnostic Technology, Inc., Wheatridge, Colorado, USA) and serum neutralization tests as previously described (Stallknecht et al., 1995) . At that time PA fawns were negative for antibodies to EHD and BT viruses, whereas TX fawns had maternal antibodies to EHD, or BT viruses, or both, confirming that they were derived from EHD virus nonendemic and endemic areas, respectively. Fawns were maintained indoors and were manually restrained and bled by jugular venipuncture weekly until they were negative for EHD antibodies by both agar gel immunodiffusion (AGID) and serum neutralization tests at a dilution of Յ1:2.
MATERIALS AND METHODS

Pennsylvania
In November, five PA and five TX fawns were experimentally infected with 10 7.1 tissue culture infective doses (TCID 50 ) of EHD virus, serotype 1 (EHDV-1). The EHDV-1 virus used in this study was originally isolated from a blood sample obtained from a clinically ill white-tailed deer from Walton County, Georgia (USA) in 1999 and was propagated and passed once on baby hamster kidney cells (BHK 21 cells; American Type Culture Collection, Rockville, Maryland, USA). It was serotyped as EHDV-1 by virus neutralization as previously described (Quist et al., 1997) .
A separate group of five PA and five TX fawns were experimentally infected with 10 7.1 TCID 50 of EHD virus, serotype 2 (EHDV-2). The EHDV-2 virus used was isolated on BHK 21 cells from a lymph node sample from a clinically ill white-tailed deer from Clarke County, Georgia. A white-tailed deer fawn, serologically negative for antibodies to EHD and BT viruses was used to prepare the inoculum. The deer was subcutaneously (SC) and intradermally (ID) inoculated with a sonicated third passage BHK 21 cell suspension-containing 10 7.4 TCID 50 . Coinciding with the first febrile episode on day 5 post-infection, the deer was anesthetized with 4.4 mg/kg of tiletamine and zolazepam (Telazol, Fort Dodge Animal Health, Fort Dodge, Iowa, USA) intramuscularly (IM) and 340 ml of blood was collected in sodium citrate. Platelet rich plasma was removed and blood cells were washed and resuspended twice with Dulbecco's phosphate-buffered saline (DPBS). This was sonicated and frozen in 10 ml aliquots at Ϫ70 C. The viral titer of this inoculum was 10 6.3 TCID 50 per ml as determined by endpoint titration. It was serotyped as EHDV-2 by virus neutralization as previously described (Quist et al., 1997) .
For both inoculations, deer were sedated with approximately 0.5 mg/kg xylazine (Xylazine-100, Butler Company, Columbus, Ohio, USA) administered IM. Half of the viral inoculum was administered SC and half ID at multiple sites on the neck. Post inoculation, sedation was reversed with 2-5 mg yohimbine (Yobine, Lloyd Laboratories, Shenandoah, Iowa) administered IM.
Beginning 4 days pre-infection and continuing every other day through post-infection day 14 (PID 14) deer were manually restrained, examined, body temperature was measured rectally, and blood was drawn via jugular venipuncture for complete blood counts, platelet counts, plasma protein, fibrinogen, viral isolation, serology and blood coagulation analyses.
Complete blood counts were performed on a Baker System 9000 automated cell counter (Baker Instrument Corporation, Allentown, Pennsylvania) . White blood cell differential counts and platelet counts were performed manually. Plasma protein was measured using a hand-held refractometer. Fibrinogen was measured by heating the plasma to 56 C for 3 min, remeasuring plasma protein post-heating, and recording the difference between the two measurements. Plasma was frozen at Ϫ70 C for later evaluation of activated partial thrombo- plastin time (APTT), prothrombin time (PT), and fibrin degradation product. All samples from each deer were run en-bloc using an Amelung KC4A Micro Coagulation Analyzer (Sigma, St. Louis, Missouri, USA) to evaluate changes in APTT and PT over the course of the experiment. Deer were tested for fibrin degradation using the D-di Test (Diagnostica Stago, Parsippany, New Jersey, USA) as described by the manufacturer. Using blood samples collected in acid citrate, virus isolation, endpoint titration, and virus identifications were performed as previously described (Quist et al., 1997) excepting that cattle pulmonary artery endothelial (CPAE) cells (American Type Culture Collection) were used for virus isolation instead of BHK 21 cells. Clinical disease severity scores (CDSS) were calculated for each deer based on the presence of certain physical and clinical parameters. Scatter plots were created for the following measured parameters for each serotype: plasma protein, APTT, PT, platelet count, lymphocyte count, fibrinogen, hematocrit, and rectal temperature. Deer were assigned one point for having at least one outlier in a parameter as determined by visually examining individual scatter plots that were created for each of the measured parameters. Deer were also allotted one point if they had degradation of fibrin in plasma at any time during the infection and one point for exhibiting each of the following clinical signs: depression, erythema of lightly haired areas, and salivation or oral lesions. The sum of all points per deer was taken as that deer's CDSS with 12 being the highest possible score and higher scores indicating more severe disease.
An overdose of pentobarbital solution was administered to all fawns for euthanasia (Beuthanasia-D Special, Schering-Plough Animal Health Corporation, Union, New Jersey). Necropsies were performed on all deer within 1 hr following euthanasia or immediately upon being found dead.
Clinical severity scores were compared by ttest (Proc TTEST, SAS, version 8e, SAS Institute Inc., Cary, North Carolina, USA). Viral and antibody titers, hematology results and clotting times were analyzed by analysis of variance (Proc GLM, SAS), with the repeated measures split plot in time model including subspecies, deer (subspecies), day post-experimental infection, and dayϫsubspecies interaction.
RESULTS
Deer became viremic by post-inoculation day (PID) 4 in both infections. Virus titers increased earlier (EHDV-1, PϽ0.001; EHDV-2, Pϭ0.003) and were higher (EHDV-1, PϽ0.001; EHDV-2, Pϭ0.06) in PA fawns than in TX fawns (Figs. 1, 2) . Clinical disease severity scores differed between PA and TX fawns for both the EHDV-1 (Pϭ0.0048) and EHDV-2 (Pϭ0.0032) infections, with PA fawns exhibiting more severe clinical disease than TX fawns (Fig. 3) . All five PA fawns infected with EHDV-1 and one of five infected with EHDV-2 died, whereas all TX fawns survived infection. Specifically, following EHDV-1 infection, two PA fawns became moribund on PID 7 and were euthanized. One PA fawn was found dead on PID 8, and the remaining two PA fawns became moribund and were euthanized on PID 9. During the EHDV-2 infection, one PA fawn became moribund on PID 13 and was euthanized. All fawns exhibited postmortem lesions consistent with HD infection.
In both infections, PA fawns showed greater decreases in lymphocyte counts (EHDV-1, Pϭ0.053; EHDV-2, PϽ0.001) and plasma protein concentrations (EHDV-1, Pϭ0.001; EHDV-2, PϽ0.001), and greater prolongation of the APTT (EHDV-1, Pϭ0.006; EHDV-2, Pϭ0.026) and PT (EHDV-1, Pϭ0.022; EHDV-2, PϽ0.001). In the EHDV-1 infection, PA fawns also exhibited a greater decrease in platelet counts (Pϭ0.076). The humoral immune response in fawns surviving to seroconversion did not vary between subspecies (PϾ0.10).
DISCUSSION
In the past it has been thought that pathogen evolution will eventually result in a pathogen with decreased virulence for its host (Allison, 1982) . This is being replaced with the idea that pathogen evolutionary adaptation to a host can result in either decreased or increased harm to the host as long as the adaptation favors successful pathogen passage into future generations (May, 1985; Lipsitch et al., 1995; Ewald, 1995) . This suggests that pathogens can evolve towards increased virulence, as long as the evolution does not result in decreased pathogen transmission. In addition to changes in pathogen virulence, pathogen-host evolution also may result in changes in host resistance as has been demonstrated in the coevolution of myxoma virus and feral Australian rabbits (Parer et al, 1994; Best et al., 2000) . The white-tailed deer-EHD virus association represents selection for host resistance without concurrent attenuation of viral virulence. Although EHD mortality is rarely reported in native Texas deer , there is clear evidence that EHDV-2 viruses circulating in Texas are virulent, despite the lack of reported clinical disease in native Texas deer. In fall 2000, EHDV-2 was isolated from whitetailed deer that died of EHD after being imported into Leon and Hunt Counties, Texas, as captive breeding stock. Despite this EHD epizootic in captive imported deer, HD was not detected in local native deer (SCWDS, unpubl. data). If EHD viruses acted as a selection force in the early evolution of Texas deer, it is possible that genetic selection favored deer with innate resistance to these viruses. Conversely, the absence, or rare presence of EHD viruses probably prevented these viruses from acting as a selection force in evolution of Pennsylvania deer.
It appears that evolutionary selection for host resistance has not resulted in decreased viral transmission. Viremias were detected a day earlier in PA fawns and peaked higher than TX fawns (Figs. 1, 2 ), but this may not be biologically significant. Viral titers in both groups of animals were sufficient to infect Culicoides (Smith et al., 1996) beyond which vectorial capacity is probably more important to EHD virus transmission than subtle differences in virus titers in the vertebrate host.
The fact that humoral immune responses were nearly identical for both subspecies implies that innate resistance rather than acquired immunity is responsible for the dramatic variation in clinical disease seen between white-tailed deer subspe-cies. The underlying mechanism of innate resistance is unknown, but differences in cell-mediated immunity or cellular response to infection might play roles in the different clinical responses seen in the two subspecies. Inherent differences in the susceptibility of cattle and sheep microvascular endothelial cells to infection by bluetongue virus, an orbivirus closely related to EHD virus, has been suggested as a reason why this virus usually causes asymptomatic infection in cattle, but severe disease in sheep (DeMaula et al., 2001) .
Differences in innate genetic resistance to diseases have been reported in wildlife at the species level. Variations in innate resistance to avian malaria have been reported in different species of native Hawaiian honeycreepers (Atkinson et al., 2000) . It also has been hypothesized that innate resistance to clinical disease caused by morbillivirus infection may explain differences in the epidemiology of this virus in harbor (Phoca vitulina) and gray (Halichoerus grypus) seals (Duignan et al., 1995) . Additionally, differences have been reported in domestic animals. For example, it has been reported (Howell, 1963) and verified by several experimental infections (Bida and Eid, 1974; Neitz, 1975; Tomori, 1980 ) that breeds of African and Asiatic domestic sheep are more resistant to infection by bluetongue virus than are European breeds. Differences in innate resistance to disease also extend to the subspecies level in wild animals as demonstrated here with EHD and white-tailed deer.
Differences in innate genetic resistance to HD are one aspect of the enzootic stability hypothesized to occur for EHD and BT viruses in native Texas deer. Should differences in innate genetic resistance to HD extend to other white-tailed deer subspecies, these differences also may help explain why severe clinical disease and mortality characterize HD epizootics, specifically EHD, in northern latitudes whereas infections in southern latitudes often result in mild or inapparent disease.
Differences in innate resistance to disease that vary on the subspecies level have major implications in managing free-ranging wildlife populations. Captive propagation, a management tool often used for endangered wildlife, is designed to retain reproductive fitness and maintain a genetically diverse population for eventual reintroduction into the wild (Montgomery et al., 1997) . Because often it is unknown to which diseases animals are innately resistant, it is a difficult proposition for captive breeding programs to account for preserving innate resistance to endemic diseases. Animals that are removed from native areas for captive propagation also may be removed from frequent and intense challenge by pathogens, a mechanism that may be responsible for maintenance of population-wide innate resistance to those pathogens. Subsequent propagation of multiple generations in captivity could result in a loss of innate resistance and a population that may never be suitable for reintroduction.
Wildlife translocation, a common wildlife management tool (Griffith et al., 1989) , may be undertaken to augment a dwindling population or to re-establish an extirpated population (Gaydos and Corn, 2001 ). Failing to consider innate resistance to disease when using this tool can result in wildlife translocation failures. When considering translocation, one concern is the potential for exposure of translocated wildlife to pathogens already present at the release area (Gaydos and Corn, 2001 ). Although it is not known if it was due to variations in susceptibility at the species or subspecies level, examples exist where translocated animals became infected by pathogens at the release site and died, resulting in translocation failure (Gaydos and Corn, 2001) . We propose that when translocation is used to augment a dwindling population, differences in innate resistance to virulent pathogens between subspecies or differences between the same species originating from different geographic locations can pose a threat to translocation success. The movement of non-resistant stocks to augment a remnant resistant population can cause the eventual genetic dilution of the beneficial disease-resistant trait held by the remnant population. Currently this is largely a theoretical consideration because so little is known about differences in disease resistance between wildlife subspecies or even between wildlife of the same species originating from different geographic locations.
